J. Petzer

发表

Phase 2 enzyme induction by the major metabolite of oltipraz.

M. Kwak, T. Kensler, J. P. Petzer, 2003, Chemical research in toxicology.

The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.

J. P. Petzer, A. Petzer, S. Mostert, 2017, European journal of medicinal chemistry.

Inhibition of Human Monoamine Oxidase: Biological and Molecular Modeling Studies on Selected Natural Flavonoids.

S. Carradori, S. Alcaro, Maria Concetta Gidaro, 2016, Journal of agricultural and food chemistry.

Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies.

S. Carradori, S. Alcaro, Maria Concetta Gidaro, 2016, Journal of agricultural and food chemistry.

Betulin, a Newly Characterized Compound in Acacia auriculiformis Bark, Is a Multi-Target Protein Kinase Inhibitor

M. Dimanche-Boitrel, M. Rousselot, B. Baratte, 2021, Molecules.

Monoamine oxidase B inhibition and neuroprotection

C. J. Van der Schyf, Jiang-Fan Chen, M. Schwarzschild, 2003, Neurology.

Methylene blue and its analogues as antidepressant compounds

B. Harvey, J. P. Petzer, A. Petzer, 2017, Metabolic Brain Disease.

Methylene blue analogues: In vitro antimicrobial minimum inhibitory concentrations and in silico pharmacophore modelling.

J. Bezuidenhout, J. P. Petzer, A. Petzer, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The Inhibition of Acetylcholinesterase by Dantrolene and Ondansetron

J. P. Petzer, A. Petzer, C. I. N'Da, 2013, Drug Research.

Multifunctional enzyme inhibition for neuroprotection: a focus on MAO, NOS, and AChE inhibitors

B. P. Repsold, J. P. Petzer, J. Joubert, 2014 .

Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties.

B. Harvey, A. Petzer, Anzelle Delport, 2014, Life sciences.

Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.

G. Wegener, B. Harvey, A. Petzer, 2012, Toxicology and applied pharmacology.

Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease

M. Schwarzschild, P. Sonsalla, J. P. Petzer, 2001, The Journal of Neuroscience.

Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors.

J. P. Petzer, A. Shetnev, A. Petzer, 2020, Bioorganic chemistry.

The evaluation of 1-tetralone and 4-chromanone derivatives as inhibitors of monoamine oxidase

L. Legoabe, J. P. Petzer, A. Petzer, 2020, Molecular diversity.

Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase

A. Petzer, A. Lourens, J. Petzer, 2020, Molecular Diversity.

The monoamine oxidase inhibition properties of selected structural analogues of methylene blue

B. Harvey, A. Petzer, Anzelle Delport, 2017, Toxicology and applied pharmacology.

Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.

A. Osipyan, A. Sapegin, S. Baykov, 2019, Bioorganic & medicinal chemistry letters.

1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B.

A. Tarasov, A. Shetnev, A. Petzer, 2019, Bioorganic & medicinal chemistry letters.

3-(3,4-Dichlorophenyl)-5-(1H-indol-5-yl)-1,2,4-oxadiazole

S. Baykov, A. Shetnev, A. Petzer, 2023, Molbank.

Indanones As High‐Potency Reversible Inhibitors of Monoamine Oxidase

J. P. Petzer, A. Petzer, S. Mostert, 2015, ChemMedChem.

The Inhibition of Monoamine Oxidase by Esomeprazole

J. P. Petzer, A. Petzer, A. Pienaar, 2013, Drug Research.

Inhibition of monoamine oxidase by indole and benzofuran derivatives.

J. P. Petzer, L. H. Prins, S. Malan, 2010, European journal of medicinal chemistry.

Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol- O-Methyltransferase and Monoamine Oxidase.

J. P. Petzer, A. Petzer, Idalet Engelbrecht, 2019, Central nervous system agents in medicinal chemistry.

The interactions of caffeine with monoamine oxidase.

J. P. Petzer, A. Petzer, A. Pienaar, 2013, Life sciences.

Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.

J. P. Petzer, N. Castagnoli, G. Terre’Blanche, 2008, Bioorganic & medicinal chemistry.

Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.

J. P. Petzer, A. Petzer, Rialette Hitge, 2020, Bioorganic & medicinal chemistry letters.

The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease

J. P. Petzer, F. Viljoen, A. Petzer, 2017, Molecules.

2-Aminopyrimidines as dual adenosine A1/A2A antagonists.

G. Terre’Blanche, J. Bergh, M. M. van der Walt, 2015, European journal of medicinal chemistry.

New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.

C. De Monte, S. Carradori, L. Mannina, 2014, European journal of medicinal chemistry.

Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues.

J. P. Petzer, J. Bergh, C. I. Manley-King, 2011, Bioorganic & medicinal chemistry.

Inhibition of monoamine oxidase by (E)-styrylisatin analogues.

D. Edmondson, J. P. Petzer, S. Malan, 2009, Bioorganic & medicinal chemistry letters.

New β-arylchalcogeno amines with procognitive properties targeting Carbonic Anhydrases and Monoamine Oxidases.

S. Carradori, C. Supuran, D. Vullo, 2022, European journal of medicinal chemistry.

The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.

B. Harvey, J. P. Petzer, A. Petzer, 2014, Toxicology and applied pharmacology.

Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.

L. Legoabe, J. P. Petzer, A. Petzer, 2012, European journal of medicinal chemistry.

Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson’s disease

E. Oztaş, M. Schwarzschild, K. Castagnoli, 2003, Neurology.

Novel monoamine oxidase inhibitors: a patent review (2012 – 2014)

S. Carradori, J. P. Petzer, J. Petzer, 2015, Expert opinion on therapeutic patents.

Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.

L. Legoabe, J. P. Petzer, A. Petzer, 2018, Bioorganic & medicinal chemistry.

The Synthesis and Evaluation of C7‐Substituted α‐Tetralone Derivatives as Inhibitors of Monoamine Oxidase

L. Legoabe, J. P. Petzer, A. Petzer, 2015, Chemical biology & drug design.

Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues

J. P. Petzer, J. Bergh, A. Petzer, 2014, The Journal of pharmacy and pharmacology.

Inhibition of monoamine oxidase by phthalide analogues.

J. P. Petzer, J. Bergh, B. Strydom, 2013, Bioorganic & medicinal chemistry letters.

MONOAMINE OXIDASE INHIBITION BY C4-SUBSTITUTED PHTHALONITRILE ANALOGUES

J. Bergh, C. I. Manley-King, J. Petzer, 2013 .

Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.

J. P. Petzer, G. Terre’Blanche, M. M. van der Walt, 2012, Bioorganic & medicinal chemistry letters.

Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.

L. Legoabe, J. P. Petzer, A. Petzer, 2012, Bioorganic chemistry.

Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.

A. J. Swanepoel, J. P. Petzer, J. Bergh, 2012, Bioorganic & medicinal chemistry.

Monoamine oxidase inhibition by C4-substituted phthalonitriles.

J. P. Petzer, J. Bergh, C. I. Manley-King, 2012, Bioorganic chemistry.

Monoamine oxidase inhibition by selected anilide derivatives.

L. Legoabe, J. P. Petzer, J. Bergh, 2011, European journal of medicinal chemistry.

Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.

J. P. Petzer, J. Bergh, C. I. Manley-King, 2011, Bioorganic & medicinal chemistry.

8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.

J. P. Petzer, J. Bergh, B. Strydom, 2011, European journal of medicinal chemistry.

Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease

Neal Castagnoli, M. Schwarzschild, Michael A. Schwarzschild, 2011, Neurotherapeutics.

8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism*

Neal Castagnoli, M. Schwarzschild, P. Sonsalla, 2002, The Journal of Biological Chemistry.

Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?

S. Carradori, C. Supuran, Mariangela Agamennone, 2022, Molecules.

Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.

K. Castagnoli, N. Castagnoli, C J Van der Schyf, 2001, Chemical research in toxicology.

Development of novel techniques to extract phenolic compounds from Romanian cultivars of Prunus domestica L. and their biological properties.

S. Carradori, G. Zengin, M. Locatelli, 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.

J. P. Petzer, S. Malan, N. Castagnoli, 2008, Bioorganic & medicinal chemistry.

Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.

M. Schwarzschild, J. P. Petzer, K. Castagnoli, 2003, Bioorganic & medicinal chemistry.

Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues.

J. P. Petzer, J. Bergh, A. Petzer, 2012, Bioorganic & medicinal chemistry.

α-Tetralone derivatives as inhibitors of monoamine oxidase.

L. Legoabe, J. P. Petzer, A. Petzer, 2014, Bioorganic & medicinal chemistry letters.

An updated patent review on monoamine oxidase (MAO) inhibitors

S. Carradori, Cristina Campestre, J. P. Petzer, 2022, Expert opinion on therapeutic patents.

Interactions of dye compounds that are structurally related to methylene blue with acetylcholinesterase and butyrylcholinesterase

J. P. Petzer, A. Petzer, Stephanus J. Cloete, 2020, Chemical Biology & Drug Design.

Monoamine oxidase inhibition by selected dye compounds

A. Petzer, J. Petzer, Franciska de Beer, 2019, Chemical biology & drug design.

Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity.

B. Harvey, J. P. Petzer, A. Petzer, 2018, ACS chemical neuroscience.

Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues.

G. Wegener, B. Harvey, S. Malan, 2010, Biochemical pharmacology.

SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs

Y. Sari, F. Alasmari, Raed Shalaby, 2019, Journal of enzyme inhibition and medicinal chemistry.

The Inhibition of Monoamine Oxidase by 8-(2-Phenoxyethoxy)Caffeine Analogues

J. P. Petzer, J. Bergh, B. Strydom, 2012, Arzneimittelforschung/Drug Research.

Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.

C. De Monte, S. Carradori, G. Zengin, 2018, European journal of medicinal chemistry.

Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase

J. P. Petzer, J. Jordaan, A. Petzer, 2019, Molecular Diversity.

The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase.

L. Legoabe, J. P. Petzer, A. Petzer, 2022, Bioorganic & medicinal chemistry letters.

C6- and C7-Substituted 3,4-dihydro-2(1H)-quinolinones as Inhibitors of Monoamine Oxidase

J. P. Petzer, A. Petzer, Letitia Meiring, 2016, Drug Research.

The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.

G. Terre’Blanche, M. M. van der Walt, A. Petzer, 2013, Bioorganic chemistry.

Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease.

A. Petzer, J. Petzer, 2015, Current medicinal chemistry.

Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase

J. P. Petzer, J. Jordaan, A. Petzer, 2019, Molecular Diversity.

4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis

S. Carradori, G. Zengin, D. Secci, 2019, Journal of enzyme inhibition and medicinal chemistry.

derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis

Zengin, S. Carradori, D. Secci, 2019 .

Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.

L. Legoabe, A. Petzer, K. T. Amakali, 2018, Central Nervous System Agents in Medicinal Chemistry.

Synthesis and in vitro Evaluation of 2-heteroarylidene-1-tetralone Derivatives as Monoamine Oxidase Inhibitors

L. Legoabe, J. P. Petzer, A. Petzer, 2018, Drug Research.

Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity

S. Carradori, G. Zengin, S. Leone, 2019, Journal of enzyme inhibition and medicinal chemistry.

derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity

Paola, S. Carradori, G. Zengin, 2019 .

The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones.

J. P. Petzer, A. Petzer, Rialette Hitge, 2022, Bioorganic & medicinal chemistry letters.

Isatoic anhydrides as novel inhibitors of monoamine oxidase.

J. P. Petzer, A. Petzer, Rialette Hitge, 2022, Bioorganic & medicinal chemistry.

Inhibition of monoamine oxidase by benzoxathiolone analogues.

J. P. Petzer, A. Petzer, S. Mostert, 2016, Bioorganic & medicinal chemistry letters.

Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.

S. Carradori, R. Silvestri, D. Secci, 2013, European journal of medicinal chemistry.

Polycyclic propargylamine and acetylene derivatives as multifunctional neuroprotective agents.

J. Joubert, S. Malan, J. Bergh, 2014, European journal of medicinal chemistry.

Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase.

J. P. Petzer, A. Petzer, E. Bester, 2022, Bioorganic chemistry.

Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of d-amino acid oxidase

A. Petzer, Stephanus J. Cloete, Roslyn Lefin, 2022, Results in Chemistry.

Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.

J. P. Petzer, H. Fourie, N. Castagnoli, 2010, Bioorganic & medicinal chemistry.

Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC).

J. P. Petzer, S. Malan, N. Castagnoli, 2006, Bioorganic & medicinal chemistry.

Monoamine oxidase inhibitory activities of heterocyclic chalcones.

J. P. Petzer, A. Petzer, A. Lourens, 2015, Bioorganic & medicinal chemistry letters.

Selected furanochalcones as inhibitors of monoamine oxidase.

J. P. Petzer, J. Bergh, A. Petzer, 2013, Bioorganic & medicinal chemistry letters.

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors

L. Legoabe, J. P. Petzer, A. Petzer, 2015, Drug design, development and therapy.

The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.

J. P. Petzer, A. Petzer, Idalet Engelbrecht, 2015, Bioorganic & medicinal chemistry letters.

The inhibition of monoamine oxidase by harmine derivatives

J. P. Petzer, A. Petzer, Theo Myburg, 2022, Results in Chemistry.

Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors.

S. Ruchaud, Richard M. Beteck, L. Legoabe, 2020, Bioorganic & medicinal chemistry.

Drug Design and Discovery in Alzheimer’s Disease

Kenneth J. Witt, M. Z. Ahmad, Eric A. Owens, 2014 .

Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors.

L. H. Prins, S. Malan, J. Petzer, 2009, Bioorganic & medicinal chemistry.

Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum)

J. P. Petzer, A. Petzer, S. van Dyk, 2019, Planta Medica.

Inhibition of monoamine oxidase B by selec- tive 7-substituted coumarin derivatives

J. P. Petzer, S. Malan, J. Bergh, 2008 .

Monoamine oxidase inhibition properties of 2,1-benzisoxazole derivatives.

S. Baykov, A. Shetnev, A. Petzer, 2023, Molecular diversity.

Leflunomide, a Reversible Monoamine Oxidase Inhibitor.

A. Petzer, J. Petzer, 2016, Central Nervous System Agents in Medicinal Chemistry.

Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists.

G. Terre’Blanche, A. L. Rousseau, A. Petzer, 2016, Bioorganic & medicinal chemistry letters.

Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.

G. Terre’Blanche, M. M. van der Walt, A. Petzer, 2017, European journal of medicinal chemistry.

Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative.

C. J. Van der Schyf, J. Wouters, F. Ooms, 2003, Bioorganic & medicinal chemistry letters.

The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.

J. P. Petzer, G. Terre’Blanche, M. M. van der Walt, 2015, Bioorganic chemistry.

2-Benzylidene-1-indanone derivatives as inhibitors of monoamine oxidase.

L. Legoabe, J. P. Petzer, A. Petzer, 2016, Bioorganic & medicinal chemistry letters.

The monoamine oxidase inhibition properties of C6- and N1-substituted 3-methyl-3,4-dihydroquinazolin-2(1H)-one derivatives

L. Legoabe, J. P. Petzer, A. Petzer, 2019, Molecular Diversity.

The monoamine oxidase inhibition properties of C6-mono- and N3/C6-disubstituted derivatives of 4(3H)-quinazolinone.

L. Legoabe, J. P. Petzer, A. Petzer, 2019, Bioorganic chemistry.

Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A1 and A2A receptor antagonists.

J. P. Petzer, G. Terre’Blanche, M. M. van der Walt, 2016, Bioorganic & medicinal chemistry letters.

An evaluation of synthetic indole derivatives as inhibitors of monoamine oxidase.

J. P. Petzer, K. Y. Suponitsky, I. Abramov, 2016, Bioorganic & medicinal chemistry letters.

Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.

J. P. Petzer, I. Abramov, A. Petzer, 2015, Bioorganic & medicinal chemistry letters.

The pterin binding site of dihydropteroate synthase (DHPS): in silico screening and in vitro antibacterial activity of existing drugs

A. Petzer, Theunis T. Cloete, J. Petzer, 2023, Results in Chemistry.

Selected chromone derivatives as inhibitors of monoamine oxidase.

L. Legoabe, A. Petzer, J. Petzer, 2012, Bioorganic & medicinal chemistry letters.

2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.

L. Legoabe, J. P. Petzer, A. Petzer, 2016, Bioorganic chemistry.

Evaluation of Natural and Synthetic 1,4‐naphthoquinones as Inhibitors of Monoamine Oxidase

J. P. Petzer, A. Petzer, S. Mostert, 2016, Chemical biology & drug design.

3-Coumaranone derivatives as inhibitors of monoamine oxidase

L. Legoabe, J. P. Petzer, A. Petzer, 2015, Drug design, development and therapy.

Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.

J. P. Petzer, A. Petzer, Roslyn Lefin, 2021, Bioorganic & medicinal chemistry.

Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.

J. P. Petzer, S. Malan, K. Castagnoli, 2007, Life sciences.

Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.

J. P. Petzer, A. Petzer, Letitia Meiring, 2013, Bioorganic & medicinal chemistry letters.

Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase.

G. Terre’Blanche, J. Bergh, A. Petzer, 2011, Bioorganic & medicinal chemistry.

Methylene blue and its analogues as antidepressant compounds

B. Harvey, J. P. Petzer, A. Petzer, 2017, Metabolic Brain Disease.

Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.

J. P. Petzer, S. Malan, N. Castagnoli, 2010, Bioorganic & medicinal chemistry.

Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues.

J. P. Petzer, S. Malan, N. Castagnoli, 2007, Bioorganic & medicinal chemistry.

Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase

J. Jordaan, A. Petzer, A. Lourens, 2019, Molecular Diversity.

Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues.

G. Wegener, B. Harvey, S. Malan, 2010, Biochemical pharmacology.

In vitro and in silico antibacterial evaluation of nitrocatechol chalcone and pyrazoline derivatives

A. Petzer, Theunis T. Cloete, J. Petzer, 2023, Results in Chemistry.

Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.

A. Petzer, Idalet Engelbrecht, J. Petzer, 2018, Central nervous system agents in medicinal chemistry.

Optimization of pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives as inhibitors of monoamine oxidase

J. P. Petzer, I. Abramov, A. Petzer, 2019, Drug development research.

Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins

L. Wiesner, H. Wong, Lizahn Laing, 2024, Frontiers in pharmacology.

Evaluation of Natural and Synthetic 1,4‐naphthoquinones as Inhibitors of Monoamine Oxidase

A. Petzer, S. Mostert, J. Petzer, 2016, Chemical Biology and Drug Design.

Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles.

J. P. Petzer, S. Malan, N. Castagnoli, 2008, Bioorganic & medicinal chemistry.

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide

A. Shetnev, A. Petzer, J. A. Efimova, 2024, Molbank.

Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats.

C. J. Van der Schyf, J. P. Petzer, N. Castagnoli, 2000, Life sciences.